head activator peptide has been researched along with Brain Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sachsenheimer, W; Schaller, HC; Winnikes, M | 1 |
| Bodenmüller, H; Sachsenheimer, W; Schaller, HC; Schilling, E; Theilmann, L | 1 |
2 other study(ies) available for head activator peptide and Brain Neoplasms
| Article | Year |
|---|---|
Head activator as a potential serum marker for brain tumour analysis.
Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Brain; Brain Neoplasms; Female; Humans; Male; Middle Aged; Neuropeptides; Postoperative Period; Pyrrolidonecarboxylic Acid; Radioimmunoassay | 1992 |
Elevated levels of head activator in human brain tumors and in serum of patients with brain and other neurally derived tumors.
Topics: Animals; Astrocytoma; Brain Neoplasms; Cell Line; Gastrointestinal Neoplasms; Glioma; Humans; Meningioma; Neuropeptides; Pituitary Neoplasms; Pyrrolidonecarboxylic Acid; Rats | 1988 |